CD34 and myeloid sarcoma: These in vitro results indicate that endothelial progenitor cells expressing markers of CD31 and CD34 endothelial progenitor cells may be targets for GLP-1 and are involved with incretin in the regeneration processes of damaged endothelium in mice with MS and pulmonary emphysema.